Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi after myocardial infarction: reply

Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):E3. doi: 10.1093/ehjcvp/pvab074.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Humans
  • Myocardial Infarction* / drug therapy
  • Off-Label Use
  • Thrombosis* / diagnosis
  • Thrombosis* / drug therapy
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Warfarin